BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19417335)

  • 1. Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers.
    Yu DG; Shen XX; Branford-White C; White K; Zhu LM; Bligh SW
    Nanotechnology; 2009 Feb; 20(5):055104. PubMed ID: 19417335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of ultrafine fast-dissolving feruloyl-oleyl-glycerol-loaded polyvinylpyrrolidone fiber mats via electrospinning.
    Quan J; Yu Y; Branford-White C; Williams GR; Yu DG; Nie W; Zhu LM
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):304-9. PubMed ID: 21798728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stochiometrically governed molecular interactions in drug: poloxamer solid dispersions.
    Ali W; Williams AC; Rawlinson CF
    Int J Pharm; 2010 May; 391(1-2):162-8. PubMed ID: 20214957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disorder and dissolution enhancement: deposition of ibuprofen on to insoluble polymers.
    Williams AC; Timmins P; Lu M; Forbes RT
    Eur J Pharm Sci; 2005 Nov; 26(3-4):288-94. PubMed ID: 16087323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution of ibuprofen from spray dried and spray chilled particles.
    Elkordy AA; Essa EA
    Pak J Pharm Sci; 2010 Jul; 23(3):284-90. PubMed ID: 20566441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
    Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
    Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO2, and their nanocomposites as appropriate drug carriers.
    Papadimitriou S; Bikiaris D
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1128-38. PubMed ID: 19555245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer-mediated disruption of drug crystallinity.
    Rawlinson CF; Williams AC; Timmins P; Grimsey I
    Int J Pharm; 2007 May; 336(1):42-8. PubMed ID: 17157459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrospun polyvinyl-alcohol nanofibers as oral fast-dissolving delivery system of caffeine and riboflavin.
    Li X; Kanjwal MA; Lin L; Chronakis IS
    Colloids Surf B Biointerfaces; 2013 Mar; 103():182-8. PubMed ID: 23201736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast Dissolving Oral Drug Delivery System Based on Electrospun Nanofibrous Webs of Cyclodextrin/Ibuprofen Inclusion Complex Nanofibers.
    Celebioglu A; Uyar T
    Mol Pharm; 2019 Oct; 16(10):4387-4398. PubMed ID: 31436100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of microviscometry to study polymer dissolution from solid dispersion drug delivery systems.
    Esnaashari S; Javadzadeh Y; Batchelor HK; Conway BR
    Int J Pharm; 2005 Mar; 292(1-2):227-30. PubMed ID: 15725569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
    Ruan LP; Yu BY; Fu GM; Zhu DN
    J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Characterization of Amorphous Nanofiber Drug Dispersions Prepared Using Pressurized Gyration.
    Raimi-Abraham BT; Mahalingam S; Davies PJ; Edirisinghe M; Craig DQ
    Mol Pharm; 2015 Nov; 12(11):3851-61. PubMed ID: 26402331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third generation solid dispersions of ferulic acid in electrospun composite nanofibers.
    Yu DG; Yang JM; Branford-White C; Lu P; Zhang L; Zhu LM
    Int J Pharm; 2010 Nov; 400(1-2):158-64. PubMed ID: 20713138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
    Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
    Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on aging piroxicam-polyvinylpyrrolidone solid dispersions.
    Ingkatawornwong S; Kaewnopparat N; Tantishaiyakul V
    Pharmazie; 2001 Mar; 56(3):227-30. PubMed ID: 11265589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.
    Kocbek P; Baumgartner S; Kristl J
    Int J Pharm; 2006 Apr; 312(1-2):179-86. PubMed ID: 16469459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution behaviour of nalidixic acid solid dispersions using water soluble dispersion carriers.
    Mallick S; Sahu A; Pal K
    Acta Pol Pharm; 2004; 61(1):21-30. PubMed ID: 15259854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.